本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CRISPR Therapeutics AG

64.76
-1.3000-1.97%
盘后64.75-0.0100-0.02%19:59 EDT
成交量:291.50万
成交额:1.90亿
市值:55.93亿
市盈率:-14.34
高:67.37
开:65.98
低:64.41
收:66.06
数据加载中...
2022/05/09

重要事件披露

8-K - Current report
2022/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/15

重要事件披露

8-K - Current report
2022/02/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/20

重要事件披露

8-K - Current report
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/14

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report
2021/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals